AU2021105956A4 - Nappy Cream - Google Patents
Nappy Cream Download PDFInfo
- Publication number
- AU2021105956A4 AU2021105956A4 AU2021105956A AU2021105956A AU2021105956A4 AU 2021105956 A4 AU2021105956 A4 AU 2021105956A4 AU 2021105956 A AU2021105956 A AU 2021105956A AU 2021105956 A AU2021105956 A AU 2021105956A AU 2021105956 A4 AU2021105956 A4 AU 2021105956A4
- Authority
- AU
- Australia
- Prior art keywords
- formulation
- weight
- skin
- nappy
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006071 cream Substances 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 83
- 238000009472 formulation Methods 0.000 claims abstract description 68
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000008213 purified water Substances 0.000 claims abstract description 12
- 239000011787 zinc oxide Substances 0.000 claims abstract description 12
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 9
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 9
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 9
- 229940116598 kakadu plum extract Drugs 0.000 claims abstract description 8
- 229940094952 green tea extract Drugs 0.000 claims abstract description 7
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 7
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 25
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000004615 ingredient Substances 0.000 claims description 16
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 11
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 8
- 229960000541 cetyl alcohol Drugs 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 101100095566 Arabidopsis thaliana SEOC gene Proteins 0.000 claims description 6
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 210000003491 skin Anatomy 0.000 description 32
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 201000004624 Dermatitis Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 240000003538 Chamaemelum nobile Species 0.000 description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 244000178870 Lavandula angustifolia Species 0.000 description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010039792 Seborrhoea Diseases 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 244000003027 Bergamotto Species 0.000 description 2
- 241000544656 Cedrus atlantica Species 0.000 description 2
- 241001672694 Citrus reticulata Species 0.000 description 2
- 244000295848 Citrus x nobilis Species 0.000 description 2
- 235000017102 Citrus x nobilis Nutrition 0.000 description 2
- 206010012444 Dermatitis diaper Diseases 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241001227551 Lavandula x intermedia Species 0.000 description 2
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000002199 base oil Substances 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- -1 sebum Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000004910 After sun product Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000031439 Striae Distensae Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- CHHHXKFHOYLYRE-STWYSWDKSA-M potassium sorbate Chemical compound [K+].C\C=C\C=C\C([O-])=O CHHHXKFHOYLYRE-STWYSWDKSA-M 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 201000003779 seborrheic infantile dermatitis Diseases 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 231100000489 sensitizer Toxicity 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229940025703 topical product Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
Abstract
A nappy cream formulation includes the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation; and
• Zinc Oxide BP, comprising 10% to 15% by weight of the formulation.
Description
This invention relates to a nappy cream. It relates particularly but not exclusively to a
protective nappy cream which creates a protective barrier against irritants and can be used to treat minor skin ailments such as burns, cuts, minor wounds, dandruff and eczema.
A nappy cream is a topical product used to place a physical barrier between the skin and
contaminants that may irritate the skin. Although the most obvious use of a nappy cream is in treating nappy rash, nappy cream is also useful for athletes who suffer from chafing,
people who suffer from bedsores, and people who are suffering dry or irritated skin.
Many nappy creams use dimethicone as a key ingredient. Dimethicone is silicon-based and
gives the cream a smooth, silky texture. However, it is often said thatdimethicone exacerbates acne by forming a barrier over skin, which traps not just moisture, but also
bacteria, skin oils, sebum, and other impurities.
According to the present invention there is provided a nappy cream formulation including the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation; and
• Zinc Oxide BP, comprising 10% to 15% by weight of the formulation.
The nappy cream formulation may include any suitable thickeners, emulsifiers, preservatives, humectants, colourants, fragrances, antioxidants and pH adjusters. Suitable
additional ingredients which fulfil these functions are:
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation;
• Glycerine, comprising 1% to 5% by weight of the formulation;
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
• Microcare PHG, comprising 0.2% to 2% by weight of the formulation;
• Polawax NF, comprising 1% to 5% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation; and
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
A method of manufacturing a nappy cream formulation according to the invention includes
the following steps:
a) Combine the purified water including Aloe Barbadensis Leaf Powder with the
glycerine and heat to 65-70°C. Sift in the Xanthan gum and mix under high shear
until fully hydrated. b) Combine the Cetyl Alcohol, Cetyl Stearyl Alcohol, Caprylic/Capric Triglyceride, Benzyl
Alcohol, Shea Butter, Jojoba Oil, Microcare PHG, and Polawax NF, and heat to 70°C. c) Combine the Green Tea Extract, Kakadu Plum Extract, SEOC Relax Me Blend, and Zinc Oxide BP.
d) Add the mixture of step (b) to the mixture of step (a) and emulsify. Stir while cooling. e) When cooled below 30°C, add the mixture of step (c). Stir until mixed thoroughly.
f) Add the Lactic Acid and continue stirring until mixed thoroughly.
g) Check and adjust the pH to the final required setting 6.0-6.5.
The invention will now be described in more detail with reference to a particular embodiment. It is to be understood that the specific details of the embodiment do not
supersede the generality of the foregoing description.
The example embodiment of a nappy cream formulation according to the present invention
includes the following ingredients:
Phase A ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation; and
• Glycerine, comprising 1% to 5% by weight of the formulation.
Phase B ingredients:
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Microcare PHG, comprising 0.2% to 2% by weight of the formulation; and
• Polawax NF, comprising 1% to 5% by weight of the formulation.
Phase C ingredients:
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation; and
• Zinc Oxide BP, comprising 10% to 15% by weight of the formulation.
Phase D ingredient:
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
The formulation is created by the following steps:
1. Combine the Purified water including Aloe Barbadensis Leaf Powder with the Glycerine and heat to 65-70°C. Sift in the Xanthan Gum and mix under high shear
until fully hydrated. 2. Combine ingredients in Phase B and heat to 70°C.
3. Add Phase B to Phase A and emulsify. Stir while cooling. 4. When cooled below 30°C, add pre-combined ingredients from Phase C. Stir until
mixed thoroughly. 5. Add Phase D ingredient and continue stirring until mixed thoroughly.
6. Check and adjust the pH to the final required setting 6.0-6.5.
This results in a viscous liquid, with a density of approximately 1.
The pH of cosmetic products should remain in a certain range so that the colour, viscosity, skin feel, and physicochemical stability remains intact during its shelf-life and during its
application by the consumer.
The pH scale ranges from 0 to 14, where a pH of 7 is neutral, while a pH less than 7 is acidic and a pH greater than 7 is basic or alkaline. The skin's normal pH is slightly acidic.
If the skin pH is too acidic (less than 5.5) it can become irritated, red, inflamed, and even painful to touch. If the skin pH is too alkaline (greater than 5.5), it can become dry,
sensitive, and the person may even develop eczema. Newborns have relatively high pH levels all over the skin. As babies get older, their pH levels decline. The average newborn has
a skin pH of about 7. This is compared to the average adult skin pH of 5.7.
It is therefore advisable when formulating washes, lotions, and creams to reach a pH between 5-7 and the general rule is that slightly acidic products are preferred and perform
better for children.
Once the formulation process has been completed it is time to measure the pH of the product, where one of these 3 possibilities can occur:
1. The pH of the product is exactly in the desired range and in the range where the
preservative system has the highest efficiency. This is unfortunately rare, and in most cases, it will be necessary either to reduce or increase the pH, dependent on the product being
formulated.
2. If the pH of the product is higher than the desired range, it needs to be reduced. Citric acid, and lactic acid are the most suitable acids to reduce the pH of a cosmetic
product.
3. If the product pH is lower than the desired range it can be increased with Sodium Citrate.
The particular ingredients and the reasons for their selection will now be described in
further detail.
Purified Water: Purified water (CAS number 7732-18-5) is combined with about 0.5% by
weight of Aloe Barbadensis Leaf Powder (CAS number 85507-69-3 / 94349-62-9). As a
cosmetic ingredient, aloe vera is widely used in many mainstream skincare and cosmetics products. The plant is skin-friendly and has a low risk of causing allergies, sensitivity or skin
reactions, and it is also versatile. It also aids protection of the epidermis and the skin's ability to restore itself and commonly used in after-sun products, facial, hair and body care.
From the juice of Aloe Vera leaves this ingredient adds a calming effect to the skin. It is known for soothing irritation and itching as well as being lightly moisturising.
Xanthan Gum (CAS number 11138-66-2): This is used in a variety of cosmetics and personal care products to help improve binding, emulsification, and thickening of the product.
Naturally plant derived and safe to use in skincare, the most effective way to disperse this gum is to blend into Glycerin to make a paste that can easily be mixed into the formulation.
Glycerine (Glycerin CAS number 56-81-5): This is used to provide smoothness and
lubrication. It is also a well-known humectant that prevents the loss of moisture from products so they don't dry out as quickly.
Cetyl Alcohol (CAS number 36653-82-4): This helps to create smoother creams, thicker
lotions, and more stable foam products. It is used to soften the skin/hair as an emollient. It is considered an effective ingredient for soothing and healing dry skin.
CSA (Cetyl Stearyl Alcohol) (CAS number 67762-27-0 / 8005-44-5): This is an emulsifier
which helps prevent creams from separating into oil and liquid. As an emollient, cetyl alcohol has the ability to soften and smooth flakiness on the skin, which helps to reduce
rough, dry skin.
GTCC (Caprylic/Capric Triglyceride) (CAS number 73398-61-5): Fractionated coconut oil of Caprylic/Capric Triglyceride is a light colourless carrier oil which will not stain clothing, is
odorless and has a long shelf life and stability, acting as an emollient, lubricant and solvent.
Butyrospermum Parkii (Shea) Butter (CAS number 194043-92-0): This has good emolliency and moisturising properties and is a skin conditioning and viscosity increasing agent.
Simmondsia Chinensis (Jojoba) Seed Oil (CAS number 90045-98-0): This is a carrier oil that
acts as a moisturizer and emollient, prevents transdermal water loss and retains moisture. It has good lubricant properties without leaving a greasy film on the skin as it penetrates.
Microcare PHG: This is composed of approximately 65% Phenoxyethanol (CAS number 122
99-6 ), and 35% Caprylyl Glycol (CAS number 1117-86-8). As a paraben and formaldehyde free preservative system, the combination of these ingredients provides optimized protection against microbial growth from both bacteria and yeast while imparting a pleasant
feel to the finished product. There are no pH restrictions and it is compatible with most raw materials.
Polawax NF: This is composed of approximately 75% Cetearyl Alcohol (CAS number 67762
27-0 / 8005-44-5) and 25% Polysorbate 60 (CAS number 9005-67-8): It is a vegetable-derived emulsifying wax and stabiliser used in lotions and creams to give them a smooth consistency
and help keep them from separating.
Kakadu Plum Extract: This is composed of approximately 19% purified water (CAS number 7732-18-5), 70% Glycerin (CAS number 56-81-5), 10% Terminalia Ferdinandiana Fruit Extract
(CAS number 1176234-54-0), and 1% Sodium Benzoate (CAS number 532-32-1). This includes a number of essential nutrients including Vitamin C, and has antiseptic wound
healing properties whilst soothing for hypersensitive skin. It is good for stretch marks, antioxidant, anti-inflammatory and antimicrobial properties, reduces redness, swelling and
skin irritation.
Green Tea Extract: This is composed of approximately 50% Glycerin (CAS number 56-81-5), 33% purified water (CAS number 7732-18-5), 15% Camellia Sinensis Leaf Extract (CAS
number 84650-60-2), and 2% Potassium Sorbate (CAS number 24634-61-5). This extract is an effective antioxidant and UV protectant, and is anti-inflammatory, anticarcinogenic and antimicrobial. It helps to speed up skin exfoliation and aids in skin hydration.
SEOC Relax Me Blend: This is composed of approximately 35% Citrus Nobilis (Mandarin
Orange Peel) Oil (CAS number 8008-31-9), 25% Cedrus Atlantica Bark (Cedarwood) Oil (CAS number 8000-27-9), 20% Lavandula Angustifolia (Lavender) Oil (CAS number 8000-28-0),
% Lavandula Hybrida Oil (CAS number 8022-15-9), 5% Citrus Aurantium Bergamia (Bergamot) Fruit Oil (CAS number 8007-75-8) and 5% Anthemis Nobilis Flower (Roman
chamomile) Oil (CAS number 84649-86-5). Citrus Nobilis (Mandarin Orange Peel) Oil has significant antioxidant properties. It is mild and calming, anti-inflammatory, and has
antimicrobial and refreshing properties. Cedrus Atlantica Bark (Cedarwood) Oil is anti inflammatory, antiseptic, and beneficial for muscular aches. It is a scalp tonic suitable for
oily skin and hair treatment such as dandruff and cradle cap. Lavandula Angustifolia
(Lavender) Oil has antiseptic and anti-inflammatory properties and is effective in treating acne, dermatitis and oily skin. It promotes rapid healing and helps reduce scarring.
Lavandula Hybrida Oil is used as a fragrance ingredient in cosmetics. Its sensitiser potential for skin is similar to that of lavender oil and camphor. Citrus Aurantium Bergamia (Bergamot) Fruit Oil has antibacterial, deodorising, refreshing, soothing, and uplifting
properties which make it suitable for body skincare preparations. Anthemis Nobilis Flower (Roman chamomile) Oil is used to help calm inflamed skin and ease skin conditions like
eczema or rashes.
Zinc Oxide (CAS number 1314-13-2): Known as a topical protectant, zinc oxide provides astringent, antiseptic and skin regenerating properties. It is used to treat minor skin
ailments such as burns, cuts, minor wounds, dandruff and eczema and can help with irritating symptoms such as itching, redness, peeling skin and inflammation. Zinc Oxide BP is
Zinc Oxide manufactured according to the British Pharmacopeia specifications.
Lactic Acid (CAS number 124-68-5), approximately 88% combined with purified water (CAS number 7732-18-5), approximately 12%: Often used as a natural pH adjuster in
formulations, lactic acid is produced by the fermentation of carbohydrates. Lactic acid
protects the skin against external influences like bacteria, allergens and pollution, while maintaining moisture.
A nappy cream formulation of the type provided by the present invention is designed to create a protective barrier against everyday irritants, as well as to treat redness and soothe
and nourish delicate skin. Zinc oxide is an active ingredient in this formulation. Known as a topical protectant, zinc oxide works by providing astringent, antiseptic and skin regenerating
properties. It is used to treat minor skin ailments such as burns, cuts, minor wounds, dandruff and eczema and can help with irritating symptoms such as itching, redness, peeling
skin and inflammation, all of which are symptoms used to describe nappy rash.
Claims (3)
1. A nappy cream formulation including the following active ingredients:
• Purified water with approximately 0.5% by weight Aloe Barbadensis Leaf Powder,
together comprising 60% to 90% by weight of the formulation;
• Shea Butter, comprising 1% to 5% by weight of the formulation;
• Jojoba Oil, comprising 1% to 5% by weight of the formulation;
• Green Tea Extract, comprising 0.05% to 1% by weight of the formulation;
• Kakadu Plum Extract, comprising 0.05% to 1% by weight of the formulation; and
• Zinc Oxide BP, comprising 10% to 15% by weight of the formulation.
2. A nappy cream formulation according to claim 1 including the following additional ingredients:
• Xanthan Gum, comprising 0.1% to 1% by weight of the formulation;
• Glycerine, comprising 1% to 5% by weight of the formulation;
• Cetyl Alcohol, comprising 1% to 5% by weight of the formulation;
• Cetyl Stearyl Alcohol, comprising 0.5% to 5% by weight of the formulation;
• Caprylic/Capric Triglyceride, comprising 5% to 10% by weight of the formulation;
• Benzyl Alcohol, comprising 0.1% to 1% by weight of the formulation;
• Microcare PHG, comprising 0.2% to 2% by weight of the formulation;
• Polawax NF, comprising 1% to 5% by weight of the formulation;
• SEOC Relax Me Blend, comprising 0.1% to 5% by weight of the formulation; and
• Lactic Acid, comprising 0.05% to 1% by weight of the formulation.
3. A method of manufacturing a nappy cream formulation according to claim 2
including the following steps:
a) Combine the Purified water including Aloe Barbadensis Leaf Powder with the Glycerine and heat to 65-70°C. Sift in the Xanthan Gum and mix under high shear
until fully hydrated.
b) Combine the Cetyl Alcohol, Cetyl Stearyl Alcohol, Caprylic/Capric Triglyceride, Benzyl Alcohol, Shea Butter, Jojoba Oil, Microcare PHG, and Polawax NF, and heat to 70°C.
c) Combine the Green Tea Extract, Kakadu Plum Extract, SEOC Relax Me Blend, and Zinc Oxide BP.
d) Add the mixture of step (b) to the mixture of step (a) and emulsify. Stir while cooling. e) When cooled below 30°C, add the mixture of step (c). Stir until mixed thoroughly.
f) Add the Lactic Acid and continue stirring until mixed thoroughly. g) Check and adjust the pH to the final required setting 6.0-6.5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021105956A AU2021105956A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021105956A AU2021105956A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021105956A4 true AU2021105956A4 (en) | 2021-10-28 |
Family
ID=78179596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021105956A Active AU2021105956A4 (en) | 2021-08-19 | 2021-08-19 | Nappy Cream |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021105956A4 (en) |
-
2021
- 2021-08-19 AU AU2021105956A patent/AU2021105956A4/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571373B2 (en) | Skin care preparations for babies | |
KR101987903B1 (en) | Cosmetic composition for treating atopic dermatitis and method thereof | |
JPH08505630A (en) | Pharmaceutical and skin cosmetic compositions containing equine colostrum | |
WO2022222215A1 (en) | Skin care composite essence oil | |
KR20200113600A (en) | Composition for hairloss and scalp care | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR20090041886A (en) | Vegetable triple moisturizing component and skin care composition comprising the same | |
KR102217697B1 (en) | Aromatherapy composition comprising natural aroma oil | |
CN112472653A (en) | Acne-removing aloe gel and preparation method thereof | |
US20200030398A1 (en) | Skin care composition | |
CN108938514B (en) | Skin-clearing acne-removing liquid and preparation method thereof | |
CN114748394A (en) | Makeup removing cream and preparation method thereof | |
US20040234628A1 (en) | Topical composition for the treatment of skin disorders and methods of using the same | |
US10111827B2 (en) | Hair loss prevention and restoration solution | |
AU2021105956A4 (en) | Nappy Cream | |
AU2021105959A4 (en) | Nappy Cream | |
EP1192940A1 (en) | Compositions and methods for promoting clear skin using an alkanolamine | |
KR102701789B1 (en) | Hair care composition | |
AU2021105957A4 (en) | Body Lotion | |
CN116831956A (en) | Moisturizing emulsion capable of relieving dry skin itching and preparation method thereof | |
CN115737488A (en) | Oil-removing, acne-astringing, mite-eliminating, anti-inflammation and antibacterial soap liquid and preparation method thereof | |
US10596090B2 (en) | Cosmetic formulation to reduce facial flushing | |
AU2021105954A4 (en) | Multi-purpose mineral bodywash | |
AU2021105955A4 (en) | Hair and body wash | |
AU2021105958A4 (en) | Body Oil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) |